Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Perhexiline 是一种口服活性的 CPT1和 CPT2抑制剂,可降低脂肪酸的代谢。Perhexiline 可以穿过血脑屏障 (BBB)具有抗癌活性。Perhexiline 诱导肝细胞中的线粒体功能障碍和细胞凋亡。因此,Perhexiline 可用于研究癌症和心绞痛等心血管疾病。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 14,900 | 8-10周 | ||
50 mg | ¥ 19,420 | 8-10周 | ||
100 mg | ¥ 24,625 | 8-10周 |
Perhexiline 的其他形式现货产品:
产品描述 | Perhexiline is an orally active inhibitor of CPT1 and CPT2 that reduces fatty acid metabolism. Perhexiline can cross the blood-brain barrier (BBB) and exhibits anti-tumor activity. Perhexiline induces mitochondrial dysfunction and apoptosis in hepatocytes. Therefore, Perhexiline can be used in cancer and cardiovascular disease research [1] [2] [5]. |
体外活性 | Perhexiline (5-25 μM, 2-6 h) reduces cell viability in HepG2 cells [2]. Perhexiline (5-25 μM, 2-6 h) reduces cellular ATP content and Lactate dehydrogenase (LDH) release in HepG2 cells [2]. Perhexiline (20 μM, 2 h) activates caspase 3/7 in HepG2 cells [2]. Perhexiline (5-25 μM, 4 h) causes mitochondrial dysfunction in HepG2 cells [2]. Perhexiline (5 μM, 48 h) selectively induces massive apoptosis in CLL cells (high expression of CPT) [3]. Cell Viability Assay [2] Cell Line: HepG2 cells Concentration: 5, 10, 15, 25 μM Incubation Time: 2, 4, 6 h Result: Induced time- and concentration-dependent cytotoxicity in hepatic cells. Western Blot Analysis [2] Cell Line: HepG2 cells Concentration: 5, 10, 15, 25 μM Incubation Time: 2 h Result: Reduced Bcl-2 and Mcl-1 level, and increased Bad level. |
体内活性 | Perhexiline (200 mg/kg, p.o., daily for 8 weeks) reduces peripheral neural function in female DA rats [4]. Perhexiline (80 mg/kg, oral gavage, for 3 days) demonstrates anti-tumor activity in glioblastoma mouse model [5]. Animal Model: Orthotopic glioblastoma mouse model [5] Dosage: 80 mg/kg Administration: Oral gavage, for 3 days. Result: Reduces tumor size (MR imaging) and improves in overall survival. |
分子量 | 277.49 |
分子式 | C19H35N |
CAS No. | 6621-47-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Perhexiline 6621-47-2 Inhibitor inhibitor inhibit